SEC FORM 4
$1,426.75
TriSalus Life Sciences, Inc. (TLSI)
Sale of 325 shares at $4.39 per share.
Reporting Person Marshak Richard · Officer Title Chief Commercial Officer · Transaction Code S
Traded Oct 5, 2026 · Disclosed Oct 7, 2026
Source: SEC Form 4 · 0001628280-26-065325 · filed 2026-10-07 · View filing →